Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
ADXN — Addex Therapeutics Ltd
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

DEC 4, 2025
REVENUE
$29724 -18.3%
NET MARGIN
-5306.3% -244.6 PTS
EPS
-$1.67 +34.8%
FREE CASH FLOW
-$533203 -27.0%

No summary has been written for this call yet.